Home › Funds › PSP Research LLC › KNSA

PSP Research LLC position in KNSA

KINIKSA PHARMACEUTICALS INTL · Health Care

PSP Research LLC reported holding 3,500 shares of KNSA (KINIKSA PHARMACEUTICALS INTL) in its Q3 2026 13F filing — a position valued at US$261K, representing 0.18% of its reported portfolio and ranking #14 among its reported holdings. PSP Research LLC has disclosed KNSA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)3.50K sh
Reported value held$261.13K
Portfolio Weight0.18%
First reportedQ4 2025
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How PSP Research LLC's KNSA position evolved

PSP Research LLC first disclosed a stake in KNSA in Q4 2025 at 12,655 shares (US$522K). Across 4 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 3,500 shares valued at US$261K — a reduction of -1,500 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2026 (shares rose 33% over the following quarter), a 44% trim in Q2 2026 (shares rose 17% over the following quarter), a 30% trim in Q3 2026 (shares rose 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 12.65K $522.02K New
Q1 2026 9.00K $433.35K Reduce
Q2 2026 5.00K $319.75K Reduce
Q3 2026 3.50K $261.13K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL) is a Health Care company. 49 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has PSP Research LLC held KNSA?

PSP Research LLC has disclosed KNSA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is PSP Research LLC's current position in KNSA?

As of Q3 2026, PSP Research LLC holds 3.50K shares of KNSA (KINIKSA PHARMACEUTICALS INTL), valued at $261.13K, representing 0.18% of its reported portfolio and ranking #14.

Has PSP Research LLC been buying or selling KNSA?

In the latest 13F filing (Q3 2026), PSP Research LLC reduced its position in KNSA.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.